Aldosterone aggravates glucose intolerance induced by high fructose

European Journal of Pharmacology

Volumn 720, Issue 1-3, 2013, Pages 63-68

  Sherajee, Shamshad J ^a   Rafiq, Kazi ^a   Nakano, Daisuke ^a   Mori, Hirohito ^a   Kobara, Hideki ^a   Hitomi, Hirofumi ^a   Fujisawa, Yoshihide ^a   Kobori, Hiroyuki ^a   Masaki, Tsutomu ^a   Nishiyama, Akira ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Aldosterone; Fructose; Insulin resistance

Indexed keywords

ADIPONECTIN; ALDOSTERONE; FRUCTOSE; GLUCOSE; INSULIN; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; SPIRONOLACTONE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; GENE; GENE TARGETING; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; MALE; MR GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SOLEUS MUSCLE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

ALDOSTERONE; FRUCTOSE; INSULIN RESISTANCE;

ALDOSTERONE; ANIMALS; BLOOD GLUCOSE; FRUCTOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; IMMEDIATE-EARLY PROTEINS; INSULIN; INSULIN RESISTANCE; MALE; MINERALOCORTICOID RECEPTOR ANTAGONISTS; MUSCLE, SKELETAL; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SPIRONOLACTONE;

EID: 84890127106     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.10.051     Document Type: Article

References (36)

1. H. Basciano, A.E. Miller, M. Naples, C. Baker, R. Kohen, E. Xu, Q. Su, E.M. Allister, M.B. Wheeler, and K. Adeli Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis Am. J. Physiol. Endocrinol. Metab. 297 2009 E462 473
2. C. Catena, R. Lapenna, S. Baroselli, E. Nadalini, G. Colussi, M. Novello, G. Favret, A. Melis, A. Cavarape, and L.A. Sechi Insulin sensitivity in patients with primary aldosteronism: a follow-up study J. Clin. Endocrinol. Metab. 91 2006 3457 3463 (Pubitemid 44402119)
3. M. Chandran, S.A. Phillips, T. Ciaraldi, and R.R. Henry Adiponectin: more than just another fat cell hormone? Diabetes Care 26 2003 2442 2450 (Pubitemid 36993340)
4. J.W. Conn Hypertension, the potassium ion and impaired carbohydrate tolerance N. Engl. J. Med. 273 1965 1135 1143
5. J.W. Conn, R.F. Knopf, and R.M. Nesbit Clinical characteristics of primary aldosteronism from an analysis of 145 cases Am. J. Surg. 107 1964 159 172
6. J.M. Connell, and E. Davies The new biology of aldosterone J. Endocrinol. 186 2005 1 20 (Pubitemid 41015660)
7. S. Dai, and J.H. McNeill Fructose-induced hypertension in rats is concentration- and duration-dependent J. Pharmacol. Toxicol. Methods 33 1995 101 107
8. J.J. Diez, and P. Iglesias The role of the novel adipocyte-derived hormone adiponectin in human disease Eur. J. Endocrinol. 148 2003 293 300 (Pubitemid 36410714)
9. B. Dong, M. Wu, H. Li, F.B. Kraemer, K. Adeli, N.G. Seidah, S.W. Park, and J. Liu Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters J. Lipid Res. 51 2010 1486 1495
10. F. Fallo, C. Pilon, and R. Urbanet Primary aldosteronism and metabolic syndrome Horm. Metab. Res. 44 2012 208 214
11. F. Fallo, F. Veglio, C. Bertello, N. Sonino, P. Della Mea, M. Ermani, F. Rabbia, G. Federspil, and P. Mulatero Prevalence and characteristics of the metabolic syndrome in primary aldosteronism J. Clin. Endocrinol. Metab. 91 2006 454 459 (Pubitemid 43236909)
12. L. Ferder, M.D. Ferder, and F. Inserra The role of high-fructose corn syrup in metabolic syndrome and hypertension Curr. Hypertens. Rep. 12 2010 105 112
13. E. Ferrannini, and A. Natali Essential hypertension, metabolic disorders, and insulin resistance Am. Heart J. 121 1991 1274 1282
14. E.M. Freel, I.K. Tsorlalis, J.D. Lewsey, R. Latini, A.P. Maggioni, S. Solomon, B. Pitt, J.M. Connell, and J.J. McMurray Aldosterone status associated with insulin resistance in patients with heart failure - data from the ALOFT study Heart 95 2009 1920 1924
15. R. Garg, S. Hurwitz, G.H. Williams, P.N. Hopkins, and G.K. Adler Aldosterone production and insulin resistance in healthy adults J. Clin. Endocrinol. Metab. 95 2010 1986 1990
16. G. Giacchetti, V. Ronconi, F. Turchi, L. Agostinelli, F. Mantero, S. Rilli, and M. Boscaro Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study J. Hypertens. 25 2007 177 186 (Pubitemid 44885680)
17. C. Guo, V. Ricchiuti, B.Q. Lian, T.M. Yao, P. Coutinho, J.R. Romero, J. Li, G.H. Williams, and G.K. Adler Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines Circulation 117 2008 2253 2261
18. M. Haluzik, G. Sindelka, J. Widimsky Jr., M. Prazny, T. Zelinka, and J. Skrha Serum leptin levels in patients with primary hyperaldosteronism before and after treatment: relationships to insulin sensitivity J. Hum. Hypertens. 16 2002 41 45 (Pubitemid 34134092)
19. A. Hirata, N. Maeda, A. Hiuge, T. Hibuse, K. Fujita, T. Okada, S. Kihara, T. Funahashi, and I. Shimomura Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice Cardiovasc. Res. 84 2009 164 172
20. H. Hitomi, H. Kiyomoto, A. Nishiyama, T. Hara, K. Moriwaki, K. Kaifu, G. Ihara, Y. Fujita, T. Ugawa, and M. Kohno Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells Hypertension 50 2007 750 755 (Pubitemid 47442741)
21. H. Kobori, Y. Ozawa, Y. Suzaki, and A. Nishiyama Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats J. Am. Soc. Nephrol. 16 2005 2073 2080 (Pubitemid 41716438)
22. E. Kumagai, H. Adachi, D.R. Jacobs Jr., Y. Hirai, M. Enomoto, A. Fukami, M. Otsuka, S. Kumagae, Y. Nanjo, K. Yoshikawa, E. Esaki, K. Yokoi, K. Ogata, A. Kasahara, E. Tsukagawa, K. Ohbu-Murayama, and T. Imaizumi Plasma aldosterone levels and development of insulin resistance: prospective study in a general population Hypertension 58 2011 1043 1048
23. G. Lastra, A. Whaley-Connell, C. Manrique, J. Habibi, A.A. Gutweiler, L. Appesh, M.R. Hayden, Y. Wei, C. Ferrario, and J.R. Sowers Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG (mRen2) 27 rat Am. J. Physiol. Endocrinol. Metab. 295 2008 E110 116
24. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419 (Pubitemid 15018832)
25. S. Matsumoto, K. Takebayashi, and Y. Aso The effect of spironolactone on circulating adipocytokines in patients with type 2 diabetes mellitus complicated by diabetic nephropathy Metabolism 55 2006 1645 1652 (Pubitemid 44827131)
26. Y. Nagai, K. Miyata, G.P. Sun, M. Rahman, S. Kimura, A. Miyatake, H. Kiyomoto, M. Kohno, Y. Abe, M. Yoshizumi, and A. Nishiyama Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts Hypertension 46 2005 1039 1045
27. S. Nakano, N. Kobayashi, K. Yoshida, T. Ohno, and H. Matsuoka Cardioprotective mechanisms of spironolactone associated with the angiotensin-converting enzyme/epidermal growth factor receptor/extracellular signal-regulated kinases, NAD(P)H oxidase/lectin-like oxidized low-density lipoprotein receptor-1, and Rho-kinase pathways in aldosterone/salt-induced hypertensive rats Hypertens. Res 28 2005 925 936 (Pubitemid 43173963)
28. A. Nishiyama, L. Yao, Y. Nagai, K. Miyata, M. Yoshizumi, S. Kagami, S. Kondo, H. Kiyomoto, T. Shokoji, S. Kimura, M. Kohno, and Y. Abe Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats Hypertension 43 2004 841 848 (Pubitemid 38405598)
29. B.M. Popkin, L.E. Armstrong, G.M. Bray, B. Caballero, B. Frei, and W.C. Willett A new proposed guidance system for beverage consumption in the United States Am. J. Clin. Nutr. 83 2006 529 542 (Pubitemid 44699197)
30. J. Selvaraj, T. Muthusamy, C. Srinivasan, and K. Balasubramanian Impact of excess aldosterone on glucose homeostasis in adult male rat Clin. Chim. Acta 407 2009 51 57
31. J. Selvaraj, S. Sathish, C. Mayilvanan, and K. Balasubramanian Excess aldosterone-induced changes in insulin signaling molecules and glucose oxidation in gastrocnemius muscle of adult male rat Mol. Cell. Biochem 372 2013 113 126
32. S.J. Sherajee, Y. Fujita, K. Rafiq, D. Nakano, H. Mori, T. Masaki, T. Hara, M. Kohno, A. Nishiyama, and H. Hitomi Aldosterone induces vascular insulin resistance by increasing insulin-like growth factor-1 receptor and hybrid receptor Arterioscler. Thromb. Vasc. Biol. 32 2012 257 263
33. S. Stas, A.T. Whaley-Connell, and J.R. Sowers Aldosterone and hypertension in the cardiometabolic syndrome J. Clin. Hypertens 10 2008 94 96
34. M. Suzuki, C. Nomura, H. Odaka, and H. Ikeda Effect of an insulin sensitizer, pioglitazone, on hypertension in fructose-drinking rats Jpn. J. Pharmacol. 74 1997 297 302 (Pubitemid 27401773)
35. L. Tappy, and K.A. Le Metabolic effects of fructose and the worldwide increase in obesity Physiol. Rev. 90 2010 23 46
36. T.A. Tobey, C.E. Mondon, I. Zavaroni, and G.M. Reaven Mechanism of insulin resistance in fructose-fed rats Metabolism 31 1982 608 612 (Pubitemid 12112253)